Skip to main content

Find Clinical Trials

Home
Conditions
Genetic Diseases, Inborn

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,627 public trials 2,162 recruiting studies

Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

NCT06351358

Conditions: Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Somenek + Pittman MD: Advanced Plastic Surgery Washington D.C., District of Columbia, United States

Lorenc Aesthetic Plastic Surgery Center New York, United States

View Trial Details

Completed

Lipoic Acid Supplement for Cystine Stone

NCT02910531

Conditions: Calculi, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinuria, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

NCT04046224

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of California, Irvine Irvine, California, United States

University of South Florida Tampa, Florida, United States

Emory University School of Medicine Atlanta, Georgia, United States

Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View all 18 locations

View Trial Details

Completed

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

NCT06629220

Conditions: Behavior, Behavioral Symptoms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Flemish Centre of Expertise in Suicide Prevention, Ghent University Ghent, Belgium

View Trial Details

Completed

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

NCT06891040

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Chinese Academy of Medical Sciences Hospital of Skin Disease Nanjing, Jiangsu, China

View Trial Details

Completed

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

NCT07329101

Conditions: Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Hangzhou First People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Investigating the Impact of JASPER Behavioral Therapy in Children With Down Syndrome

NCT05638412

Conditions: Abnormalities, Multiple, Behavior, Chromosome Disorders, +12 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.

NCT06277245

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Dermatological Hospital of Southern Medical University Guangzhou, China

View Trial Details

Completed

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

NCT04577352

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations: UCLA Los Angeles, California, United States

University of Florida Gainesville, Florida, United States

University of South Florida Tampa, Florida, United States

University of Iowa Iowa City, Iowa, United States

View all 14 locations

View Trial Details

Completed

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

NCT03213665

Conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 117 locations

View Trial Details